References
- O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009;373(9678):1891–1904.
- Flume PA, Mogayzel PJ, Robinson KA, et al. Cystic Fibrosis Pulmonary Guidelines: pulmonary Complications: hemoptysis and Pneumothorax. Am J Respir Crit Care Med. 2010 Aug 1;182(3):298–306.
- Flume PA, Yankaskas JR, Ebeling M, et al. Massive hemoptysis in cystic fibrosis. Chest. 2005;128(2):729–738.
- Brinson GM, Noone PG, Mauro MA, et al. Bronchial Artery Embolization for the Treatment of Hemoptysis in Patients with Cystic Fibrosis. Am J Respir Crit Care Med. 1998;157(6):1951–1958.
- Thompson V, Mayer-Hamblett N, Kloster M, et al. Risk of hemoptysis in cystic fibrosis clinical trials: a retrospective cohort study. J Cyst Fibros. 2015;14(5):632–638.
- Jagannath VA, Fedorowicz Z, Thaker V, et al. Vitamin K supplementation for cystic fibrosis. Cochrane Database Syst Rev. 2015;1:CD008482.
- Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med. 1994 Sep 8;331(10):637–642.
- Drury D, Grey VL, Ferland G, et al. Efficacy of high dose phylloquinone in correcting vitamin K deficiency in cystic fibrosis. J Cyst Fibros. 2008;7(5):457–459.
- Beker LT, Ahrens RA, Fink RJ, et al. Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr. 1997;24(5):512–517.
- Kleinman RE, Fracchia MS, Vitamin K, et al. Am J Clin Nutr. 2010;92(3):460–470.
- Sinaasappel M, Stern M, Littlewood J, et al. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros. 2002;1(2):51–75.
- Martínez-moneo E, Stigliano S, Hedström A, et al. Deficiency of fat-soluble vitamins in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology. 2016;16(6):988–994.
- Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry. 2018 Annual. Data Report. Bethesda, Maryland, 2018.
- Gavioli E, Aung CC. Haemoptysis management in cystic fibrosis: a case report and treatment pathway. J Clin Pharm Ther. 2020 Aug;45(4):845–847.
- Efrati O, Harash O, Rivlin J, et al. Hemoptysis in Israeli CF patients — prevalence, treatment, and clinical characteristics. J Cyst Fibros. 2008;7(4):301–306.
- Krzyzanowska P, Pogorzelski A, Wojciech S, et al. Exogenous and endogenous determinants of vitamin K status in cystic fibrosis. Sci Rep. 2015;5(1):12000.
- Takemoto CM. Venous thromboembolism in cystic fibrosis. Pediatr Pulmonol. 2012;47(2):105–112.